Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations (Parenthetical)

v3.21.4
Consolidated Statements of Operations (Parenthetical) - USD ($)
12 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Research and Development Expense [Member]    
Share-based payment arrangement, expense $ 4,165,668 $ 1,484,545
General and Administrative Expense [Member]    
Share-based payment arrangement, expense $ 3,892,410 $ 2,652,915